» Articles » PMID: 38283623

Virus-like Particles (VLPs): A Promising Platform for Combating Against Newcastle Disease Virus

Overview
Journal Vaccine X
Date 2024 Jan 29
PMID 38283623
Authors
Affiliations
Soon will be listed here.
Abstract

The global poultry industry plays a pivotal role in providing eggs and meat for human consumption. However, outbreaks of viral disease, especially Newcastle virus disease (NDV), within poultry farms have detrimental effects on various zootechnical parameters, such as body weight gain, feed intake, feed conversion ratio, as well as the quality of egg and meat production. Cases of vaccine failure have been reported in regions where highly pathogenic strains of NDV are prevalent. To tackle this challenge, virus-like particles (VLPs) have emerged as a potential solution. VLPs closely resemble natural viruses, offering biocompatibility and immune-stimulating properties that make them highly promising for therapeutic applications against NDV. Hence, this review emphasizes the significance of NDV and the need for effective treatments. The manuscript will contain several key aspects, starting with an exploration of the structure and properties of NDV. Subsequently, the paper will delve into the characteristics and benefits of VLPs compared to conventional drug delivery systems. A comprehensive analysis of VLPs as potential vaccine candidates targeting NDV will be presented, along with a discussion on strategies for loading cargo into these NDV-targeting VLPs. The review will also examine various expression systems utilized in the production of NDV-targeting VLPs. Additionally, the manuscript will address future prospects and challenges in the field, concluding with recommendations for further research.

Citing Articles

The Use of Plant Viral Nanoparticles in Cancer Biotherapy-A Review.

Komane M, Kayoka-Kabongo P, Rutkowska D Viruses. 2025; 17(2).

PMID: 40006973 PMC: 11860677. DOI: 10.3390/v17020218.


The Role of Plant Virus-like Particles in Advanced Drug Delivery and Vaccine Development: Structural Attributes and Application Potential.

Peralta-Cuevas E, Garcia-Atutxa I, Huerta-Saquero A, Villanueva-Flores F Viruses. 2025; 17(2).

PMID: 40006903 PMC: 11861432. DOI: 10.3390/v17020148.


Recent progress of principal techniques used in the study of Müller glia reprogramming in mice.

Yin Z, Kang J, Xu H, Huo S, Xu H Cell Regen. 2024; 13(1):30.

PMID: 39663301 PMC: 11635068. DOI: 10.1186/s13619-024-00211-z.


Development of a genotype-matched Newcastle disease DNA vaccine candidate adjuvanted with IL-28b for the control of targeted velogenic strains of Newcastle disease virus in Africa.

Amoia C, Chengula A, Hakizimana J, Wambura P, Munir M, Misinzo G Vet Res Commun. 2024; 49(1):33.

PMID: 39585481 PMC: 11588948. DOI: 10.1007/s11259-024-10590-y.


Virus-like particles in poultry disease: an approach to effective and safe vaccination.

Raji A, Dastjerdi P, Omar A Front Vet Sci. 2024; 11:1405605.

PMID: 39315089 PMC: 11417104. DOI: 10.3389/fvets.2024.1405605.

References
1.
Elizondo-Gonzalez R, Cruz-Suarez L, Ricque-Marie D, Mendoza-Gamboa E, Rodriguez-Padilla C, Trejo-Avila L . In vitro characterization of the antiviral activity of fucoidan from Cladosiphon okamuranus against Newcastle Disease Virus. Virol J. 2012; 9:307. PMC: 3546940. DOI: 10.1186/1743-422X-9-307. View

2.
Berinstein A, Vazquez-Rovere C, Asurmendi S, Gomez E, Zanetti F, Zabal O . Mucosal and systemic immunization elicited by Newcastle disease virus (NDV) transgenic plants as antigens. Vaccine. 2005; 23(48-49):5583-9. DOI: 10.1016/j.vaccine.2005.06.033. View

3.
Wu X, Zhai X, Lai Y, Zuo L, Zhang Y, Mei X . Construction and Immunogenicity of Novel Chimeric Virus-Like Particles Bearing Antigens of Infectious Bronchitis Virus and Newcastle Disease Virus. Viruses. 2019; 11(3). PMC: 6465995. DOI: 10.3390/v11030254. View

4.
Aguilar-Briseno J, Cruz-Suarez L, Sassi J, Ricque-Marie D, Zapata-Benavides P, Mendoza-Gamboa E . Sulphated polysaccharides from Ulva clathrata and Cladosiphon okamuranus seaweeds both inhibit viral attachment/entry and cell-cell fusion, in NDV infection. Mar Drugs. 2015; 13(2):697-712. PMC: 4344596. DOI: 10.3390/md13020697. View

5.
Zhao J, Yang H, Xu H, Ma Z, Zhang G . Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza. Virol J. 2017; 14(1):56. PMC: 5356287. DOI: 10.1186/s12985-017-0723-7. View